65
Participants
Start Date
June 25, 2019
Primary Completion Date
May 11, 2023
Study Completion Date
May 11, 2023
Rimegepant
BHV3000 (rimegepant) 75mg tablet
Placebo
Placebo
Neurological Surgery Practice of Long Island PLCC, Lake Success
Neurological Surgery, Lake Success
Premier Cardiolog Consultants, Lake Success
Premier Cardiolog Consultants, New Hyde Park
Premier Cardiology Consultants, New Hyde Park
North Suffolk Neurology, PC, Port Jefferson Station
Dent Neurosciences Research Center, Amherst
Johns Hopkins Clinical Outpatient Center, Baltimore
Johns Hopkins ICTR Clinical Research Unit (CRU), Baltimore
SouthCoast Research Center, Miami
Neurology Diagnostics Inc., Dayton
Clinical Research Professionals, Chesterfield
Ochsner Baptist Medical Center, New Orleans
Gilbert Neurology Partners, PLLC/CCT Research, Gilbert
Center for Neurohealth DBA Kaizen Brain Center, La Jolla
Imaging Clinic at Stanford Neuroscience Health Center, Palo Alto
Stanford Hoover Pavilion, Palo Alto
Stanford Neuroscience Health Center- SNHC Pharmacy, Palo Alto
Stanford Neuroscience Health Center, Palo Alto
Stanford University- CAM Building, Stanford
Lead Sponsor
Pfizer
INDUSTRY